| Literature DB >> 23255577 |
Michael Zeisberg1, Raghu Kalluri.
Abstract
Fibrosis is a pathological scarring process that leads to destruction of organ architecture and impairment of organ function. Chronic loss of organ function in most organs, including bone marrow, heart, intestine, kidney, liver, lung, and skin, is associated with fibrosis, contributing to an estimated one third of natural deaths worldwide. Effective therapies to prevent or to even reverse existing fibrotic lesions are not yet available in any organ. There is hope that an understanding of common fibrosis pathways will lead to development of antifibrotic therapies that are effective in all of these tissues in the future. Here we review common and organ-specific pathways of tissue fibrosis.Entities:
Mesh:
Year: 2012 PMID: 23255577 PMCID: PMC3566435 DOI: 10.1152/ajpcell.00328.2012
Source DB: PubMed Journal: Am J Physiol Cell Physiol ISSN: 0363-6143 Impact factor: 4.249